Remove Licensing Remove Production Remove Science
article thumbnail

Nobel Prize celebrates AI’s role in protein structure innovation

Drug Target Review

the life sciences and pharmaceutical industries increasingly rely on AI-driven discoveries, companies operating in this space will need to carefully consider how to obtain meaningful protection for both the AI platforms and the products generated by such platforms.

article thumbnail

The paradox of data in precision medicine

Drug Target Review

In many cases, life sciences organisations are using technologies that were not specifically designed for scientific data, leading to inefficiencies in both research and operations. Below are three key challenges that need to be addressed to overcome this technological bottleneck.

Science 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merkin Prize in Biomedical Technology awarded to F. William Studier for development of widely used protein- and RNA-production platform

Broad Institute

William Studier for development of widely used protein- and RNA-production platform By Corie Lok May 14, 2024 Breadcrumb Home Merkin Prize in Biomedical Technology awarded to F. Speeding science Before Studier’s development of the T7 system, scientists who wanted to produce RNA or proteins generally inserted the genes into the natural E.

RNA 84
article thumbnail

Women in STEM with Kristina Torfgard

Drug Target Review

Later, heading up early gastrointestinal projects as Global Product Director, it was exciting to reach Proof of Concept, however I was seen not experienced enough to bring this project forward in development. I experienced challenges in cultural differences working with US, UK, Japan, and China.

article thumbnail

Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases

The Pharma Data

Novartis today announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids to use in potential gene therapies for neurological diseases, with options to access capsids for two other targets.

article thumbnail

16th Annual Life Sciences Trade and Channel Strategies

Drug Channels

16th Annual Life Sciences Trade and Channel Strategies. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?

article thumbnail

The art and science of drug formulation

Drug Target Review

Drug formulation is the process of designing and producing a final medicinal product from an active pharmaceutical ingredient (API). The science behind drug formulation The formulation of a drug is both an art and a science, requiring a deep understanding of the drug’s chemical and physical properties. What is drug formulation?

Science 59